Timothy Davis
University of Western Australia, WA, Australia
- This delegate is presenting an abstract at this event.
TIMOTHY DAVIS is en endocrinologist and general physician at Fremantle Hospital, and Professor of Medicine, University of Western Australia. He has had research interests in diabetes since 1978. He is principal investigator of the Fremantle Diabetes Study, a large-scale prospective study of diabetes in a community-based cohort which has been in progress since 1993 and which has produced more than 120 published papers. He also works as an Associate Investigator on the United Kingdom Prospective Diabetes Study. His research team conducts a number of epidemiological and multi-centre pharmaceutical intervention studies. He has been a past Vice-President of the Australian Diabetes Society. He is a Co-Lead of the WA Health Department’s Diabetes and Endocrinology Clinical Network, is a member of the Busselton Population Medical Research Foundation Board, and has also served on the Council and Research Committee of the NMHRC. He also serves on the Medical Services Advisory Committee and the Commonwealth Science Council.
Presentations this author is a contributor to:
Pneumococcal vaccination and incident pneumonia in type 2 diabetes: The Fremantle Diabetes Study Phase II (#10)
10:15 AM
Timothy Davis
ADS Clinical Orals - Epidemiology & Cardiovascular Complications
Proton pump inhibitor use, mortality and endothelial dysfunction in type 2 diabetes: The Fremantle Diabetes Study Phase II (#6)
9:15 AM
Timothy Davis
ADS Clinical Orals - Epidemiology & Cardiovascular Complications
LEADER - More good news for the patients with type 2 diabetes (#154)
10:30 AM
Timothy Davis
ADS Clinical Trials Update